Proscia

Proscia is a US digital pathology company founded in 2014 and headquartered in Philadelphia, Pennsylvania. It was built to replace manual glass-slide review with software that helps pathology labs and pharmaceutical R&D teams manage rising case volumes and staff shortages.

Its Concentriq platform digitizes, stores and routes whole-slide images across a lab network; Concentriq AP-Dx is FDA-cleared for primary diagnosis and Concentriq LS supports biomarker and companion-diagnostic research. AI applications built on the platform assist with case triage and quantitative tissue analysis. Customers include more than 4,000 hospitals and clinics and 16 of the top 20 pharmaceutical companies, such as Bayer and Eli Lilly.

1. Concentriq platform: digitizes and centralizes whole-slide pathology images across labs.

2. Concentriq AP-Dx: FDA-cleared software for primary anatomic-pathology diagnosis.

3. Concentriq LS: supports biomarker discovery and companion-diagnostic research for pharma.

4. AI case triage: flags high-priority or abnormal cases for pathologist review.

5. Quantitative image analysis: measures tissue biomarkers for research and clinical use.

6. Lab network integration: connects distributed sites for remote and consult pathology.